Literature DB >> 29913745

Review of neuroimaging studies related to pain modulation.

Lone Knudsen1, Gitte Laue Petersen2, Kathrine Næsted Nørskov2, Lene Vase2, Nanna Finnerup1,3, Troels Staehelin Jensen1,3, Peter Svensson3,4.   

Abstract

BACKGROUND AND
PURPOSE: A noxious stimulus does not necessarily cause pain. Nociceptive signals arising from a noxious stimulus are subject to modulation via endogenous inhibitory and facilitatory mechanisms as they travel from the periphery to the dorsal horn or brainstem and on to higher brain sites. Research on the neural structures underlying endogenous pain modulation has largely been restricted to animal research due to the invasiveness of such studies (e.g., spinal cord transection, brain lesioning, brain site stimulation). Neuroimaging techniques (e.g., magnetoencephalography (MEG), positron emission tomography (PET) and functional magnetic resonance imaging (fMRI)) provide non-invasive means to study neural structures in humans. The aim is to provide a narrative review of neuroimaging studies related to human pain control mechanisms.
METHODS: The approach taken is to summarise specific pain modulation mechanisms within the somatosensory (diffuse noxious inhibitory controls, acupuncture, movement), affective (depression, anxiety, catastrophizing, stress) and cognitive (anticipation/placebo, attention/distraction, hypnosis)domains with emphasis on the contribution of neuroimaging studies. RESULTS AND
CONCLUSIONS: Findings from imaging studies are complex reflecting activation or deactivation in numerous brain areas. Despite this, neuroimaging techniques have clarified supraspinal sites involved in a number of pain control mechanisms. The periaqueductal grey (PAG) is one area that has consistently been shown to be activated across the majority of pain mechanisms. Activity in the rostral ventromedial medulla known to relay descending modulation from the PAG, has also been observed both during acupuncture analgesia and anxiety-induced hyperalgesia. Other brain areas that appear to be involved in a number of mechanisms are the anterior cingulate cortex, prefrontal cortex, orbitofrontal cortex and nucleus accumbens, but their exact role is less clear. IMPLICATIONS: Neuroimaging studies have provided essential information about the pain modulatory pathways under normal conditions, but much is still to be determined. Understanding the mechanisms of pain control is important for understanding the mechanisms that contribute to failed pain control in chronic pain. Applying fMRI outside the brain, such as in the trigeminal nucleus caudalis of the spinotrigeminal pathway and in the dorsal horn of the spinal cord, and coupling brain activity with activity at these sites may help improve our understanding of the function of brain sites and shed light on functional connectivity in the pain pathway.
© 2011 Scandinavian Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MEG; Neuroimaging; Nociception; PET; Pain control mechanisms; fMRI

Year:  2018        PMID: 29913745     DOI: 10.1016/j.sjpain.2011.05.005

Source DB:  PubMed          Journal:  Scand J Pain        ISSN: 1877-8860


  12 in total

1.  Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway.

Authors:  Benjamin K Lau; Bryony L Winters; Christopher W Vaughan
Journal:  Br J Pharmacol       Date:  2020-02-15       Impact factor: 8.739

2.  The sensory and affective components of pain: are they differentially modifiable dimensions or inseparable aspects of a unitary experience? A systematic review.

Authors:  K Talbot; V J Madden; S L Jones; G L Moseley
Journal:  Br J Anaesth       Date:  2019-05-01       Impact factor: 9.166

3.  Cue-elicited functional connectivity of the periaqueductal gray and tonic cocaine craving.

Authors:  Sheng Zhang; Simon Zhornitsky; Wuyi Wang; Isha Dhingra; Thang M Le; Chiang-Shan R Li
Journal:  Drug Alcohol Depend       Date:  2020-08-19       Impact factor: 4.492

4.  Acute Posttrauma Resting-State Functional Connectivity of Periaqueductal Gray Prospectively Predicts Posttraumatic Stress Disorder Symptoms.

Authors:  Elisabeth K Webb; Ashley A Huggins; Emily L Belleau; Lauren E Taubitz; Jessica L Hanson; Terri A deRoon-Cassini; Christine L Larson
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-03-28

5.  Mutation Carriers with Reduced C-Afferent Density Reveal Cortical Dynamics of Pain-Action Relationship during Acute Pain.

Authors:  I Perini; M Ceko; L Cerliani; H van Ettinger-Veenstra; J Minde; I Morrison
Journal:  Cereb Cortex       Date:  2020-07-30       Impact factor: 5.357

6.  Cognitive Inhibition Correlates with Exercise-Induced Hypoalgesia After Aerobic Bicycling in Pain-Free Participants.

Authors:  H Gajsar; C Titze; K Konietzny; M Meyer; H B Vaegter; M I Hasenbring
Journal:  J Pain Res       Date:  2020-04-29       Impact factor: 3.133

7.  Acute elevated platform triggers stress induced hyperalgesia and alters glutamatergic transmission in the adult mice anterior cingulate cortex.

Authors:  Koki Kawakami; Kohei Koga
Journal:  IBRO Neurosci Rep       Date:  2021-02-03

Review 8.  Behavioral, Psychological, Neurophysiological, and Neuroanatomic Determinants of Pain.

Authors:  Samantha M Meints; Robert R Edwards; Christopher Gilligan; Kristin L Schreiber
Journal:  J Bone Joint Surg Am       Date:  2020-05-20       Impact factor: 6.558

9.  Associations of pain catastrophizing with pain-related brain structure in individuals with or at risk for knee osteoarthritis: Sociodemographic considerations.

Authors:  Ellen L Terry; Jared J Tanner; Josue S Cardoso; Kimberly T Sibille; Song Lai; Hrishikesh Deshpande; Georg Deutsch; Burel R Goodin; Laurence A Bradley; Catherine C Price; Roger B Fillingim
Journal:  Brain Imaging Behav       Date:  2021-08       Impact factor: 3.224

10.  The dynamics of pain reappraisal: the joint contribution of cognitive change and mental load.

Authors:  Agnieszka K Adamczyk; Tomasz S Ligeza; Miroslaw Wyczesany
Journal:  Cogn Affect Behav Neurosci       Date:  2020-04       Impact factor: 3.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.